Anhui · 66-66 · CHINA
For Anhui · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Sodium Heparin; product code is 61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 361 Jixi Roadhui Kang Mansion , Anhui, CHINA, verified against its source on 2026-09-16.
- Firm
- Anhui verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CHINA verified
- Address
- 361 Jixi Roadhui Kang Mansion , Anhui, CHINA verified
- Date published
- 09/30/2009 verified
- Product code
- 61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Sodium Heparin verified
- FDA notes
- 10/10/2000 verified
What the source says
Anhui Date Published : 09/30/2009 361 Jixi Roadhui Kang Mansion , Anhui, CHINA 61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf Date Published: 10/10/2018 Desc: Sodium Heparin Notes: 10/10/2000
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.